TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled August 28, 1981
TCL Archive ‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life January 10, 1992